Move from strain to strength. Reinvent your organisation for what patients need next.

Healthcare

aviation

Malaysia's healthcare industry is being redefined by various external forces—from persistent workforce shortages and health equity gaps to rising costs of care—compounded by an ageing population and the rapid rise in non- communicable diseases (NCDs). The bar for trusted healthcare has never been higher, catalysed by advanced technologies like artificial intelligence (AI), data analytics, and telemedicine, which are enabling more personalised, predictive, and preventive treatments when and where patients need them most.​

Thriving in this dynamic ecosystem requires collaborative, cross-functional approaches that balance innovation with human-centred care.​

How we can help

Sustainable healthcare transformation is a journey which requires bold ideas, diligent execution, and an unwavering focus on patients. ​

We combine deep local insight with a global network of cross-sector expertise including technology and digital health, data analytics, deals strategy, finance, and public policy.​

Our team works across Malaysia’s healthcare ecosystem, bridging public and private sectors, to design solutions that are both innovative and practical. We leverage data-driven insights and advanced digital tools to help healthcare providers improve patient outcomes and efficiency, while ensuring that transformations are fully aligned with Malaysia’s healthcare standards and regulations. ​

Partnership and co-creation are the key differentiators to our approach, helping you realise value where it matters.  ​ ​

Shape reinvention

Efficiency, value-based care, and improved healthcare outcomes are today's markers of success. Health systems must adapt and expand their focus beyond sector boundaries—integrating primary care, home health, consumer tech, and digital platforms. We help you accelerate transformation with innovative strategies, paired with the right governance models to align stakeholders towards greater trust and interoperability. Our approach to transformation is holistic, ensuring you are well supported throughout your reinvention journey to deliver sustained value, from due diligence to progress monitoring and tracking. ​ ​ ​ ​ ​ ​ ​ ​ ​

Solve workforce challenges

Addressing persistent talent shortages demands a new approach—one that drives value through an agile, tech-enabled workplace. We help you design new staffing models and rewards systems, align your culture with change initiatives, and promote workforce development through dedicated upskilling programmes. ​ ​

Enhance your resilience

​We help you develop fit-for-purpose data architecture solutions and embed strong data governance and security protocols for the safe sharing of patient data.​ ​

Taking a resilience lens, we help you enhance your confidence amid vulnerabilities including sustainability, and regulatory and technological risks, in our connected healthcare ecosystem. ​ ​ ​ ​ ​ ​ ​ ​

Realise deal value

The appetite to pursue consolidation will continue, as healthcare moves towards flexible delivery models amid the push for greater efficiencies and value-based care. ​

Through our strategic capabilities, we will help you deliver distinctive value throughout the deals cycle—from assessing your integration readiness and verifying due diligence, to supporting you through change. ​ ​

If you're exploring divestiture, we will focus on helping you optimise your operating model and prepare robust separation plans to safeguard your core business. ​ ​ ​ ​ ​ ​ ​

Case studies

Supporting the Malaysian National COVID-19 Immunisation programme​

Summary​ ​

We were appointed by the Malaysian government to augment the overall National COVID-19 Immunisation Programme management effort. We worked alongside the Malaysian cross-ministry COVID-19 Immunisation Task Force (CITF) led by the Ministry of Science, Technology and Innovation (MOSTI) with cooperation from the Ministry of Health.

Situation​ ​

The government wanted to ensure that vaccines were provided to everyone living in Malaysia in an efficient and equitable manner. This was critical in easing restrictions for individuals and businesses for the revival of the economy.

Approach

We supported the National COVID‑19 Immunisation Programme through the following activities:

  • Conducted readiness assessments across the vaccines‑to‑vaccinations roadmap for critical workstreams​

  • Augmented the CITF Programme Management Office (PMO) to drive day‑to‑day coordination, accountability, and implementation across the programme​

  • Supported the planning and set‑up of vaccination centres, including high‑capacity mega vaccination centres​

  • Formulated and monitored national and state‑level vaccination targets and key performance indicators (KPIs)​

  • Monitored appointment management processes and public support channels ​

  • Provided supply‑demand‑utilisation optimisation analytics and monitoring support​

  • Performed risk assessments, programme assurance, and reporting

Outcomes​ ​
  • Malaysia was one of the fastest countries globally to achieve the daily vaccination rate per capita—programme targets were completed four months ahead of schedule​ 
  • A notable reduction in COVID‑19 admissions, critical hospitalisations, and deaths across the nation as the programme progressed, enabling the easing of restrictions and supporting economic recovery​ 
  • By mid‑February 2022, over 98% of the country's adult population and 89% of adolescents aged 12–17 were fully vaccinated. More than 55% of adults also received booster doses.​ 

Synergy assessment for a potential acquisition of a regional healthcare group ​

Summary​ ​

We performed a synergy assessment on the potential revenue and cost upsides, to support the valuation of a potential acquisition of a regional group of hospitals. ​ ​ ​ ​

Situation​ ​

Our client was exploring a potential acquisition of a regional healthcare group with operations across Southeast Asia. ​

We were engaged to undertake a synergy assessment for the acquisition, to help the client assess the potential future value of the investment. The synergy analysis focused on the potential revenue and cost synergies from the acquisition—benchmarked against industry players.​

​Approach​ ​ ​
  • Developed a synergy assessment model to estimate the potential revenue uplift from increased patient referrals across the broader healthcare group​

  • Identified and quantified cost savings from the vendor consolidation as well as the headcount rationalisation exercise post-acquisition​

  • Benchmarked the potential combined entity against best-in-class healthcare service providers to estimate the cost optimisation potential of the combined hospitals in the network​

Impact​ ​
  • Based on our estimated financial impact of synergies from integrating hospital operations across both groups, we developed an illustrative value bridge, highlighting the revenue and cost synergy potential from the acquisition​

  • Identified the key enablers, risks, and mitigating factors involved in achieving the proposed synergies​

Commercial due diligence for a potential investment in a HealthTech platform ​

Summary​ ​

We were engaged to conduct commercial due diligence on an employee benefits Software as a Service (SaaS) platform in Malaysia, as part of a broader integrated due diligence service that included financial and tax due diligence.

Situation​ ​

Our client needed an in-depth understanding of the market potential and competitive landscape in Malaysia, Singapore, Vietnam, and Thailand, to identify potential growth opportunities. 

​Approach​ ​ ​
  • In-depth assessment of the employee healthcare benefits market, including major trends and whitespace opportunities ​

  • Benchmarking of key competitors to establish the target’s competitive advantage ​

  • Conducted a survey on the target’s key customers to understand overall customer experience ​

  • Assessed the target’s business model, financial performance, and growth initiatives

Impact​ ​
  • Combined insights from the commercial, financial, and tax due diligence, to develop a holistic investment thesis​

  • Identified specific value levers to support the platform's future growth and pathway to profitability ​

  • Identified key deal considerations, including key risk factors, which may impact the platform's potential pathway to profitability

Development of a 5-year transformation strategy for a pharmaceutical business in Malaysia and Singapore ​

Summary​ ​

We were engaged to support a leading pharmaceutical company to develop a strategic business plan—this included a strategic review of their existing operations and the development of a 5-year value creation and transformation plan.

Situation​ ​

Our client, a large integrated pharmaceutical player in ASEAN, was seeking to expand regionally. They needed advisory services to develop a 5-year value creation strategy and transformation plan for their business. 

​Approach​ ​ ​
  • Review of the healthcare and pharmaceutical industry, including key market trends, opportunities, and the competitive landscape​

  • Analysis of the profit pools along the pharmaceutical value chain​

  • Baseline analysis of management’s business plan to evaluate opportunities for upside growth​

  • Developed a detailed 5-year transformation strategy and value creation plan, premised on findings from the market and baseline analysis

Impact​ ​

Developed a robust 5-year value creation strategy and transformation plan, which included: 

  • Value proposition to support differentiated market positioning ​

  • Product and market expansion opportunities​

  • Target operating model, key target segments, and routes to market 

  • Key operational levers for greater cost optimisation ​

  • Implementation roadmap and transformation strategy​

  • Strategic implementation plan and robust programme management framework

Follow us

Required fields are marked with an asterisk(*)

Your personal information will be handled in accordance with our Privacy Statement. You can update your communication preferences at any time by clicking the unsubscribe link in a PwC email or by submitting a request as outlined in our Privacy Statement.

Contact us

Taariq Murad

Taariq Murad

Tax Partner; Healthcare Leader; and Inclusion & Diversity Leader, PwC Malaysia

Sean Soon

Sean Soon

Deals Director, Deals Strategy and Operations, PwC Malaysia

Hide